메뉴 건너뛰기




Volumn 5, Issue 20, 2014, Pages 9930-9938

Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML

Author keywords

AML; BTK; CXCR4; Ibrutinib; SDF1

Indexed keywords

BETA ACTIN; BRUTON TYROSINE KINASE; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; IBRUTINIB; INTERLEUKIN 2; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR RUNX1; AGAMMAGLOBULINAEMIA TYROSINE KINASE; CXCL12 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

EID: 84924963486     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2479     Document Type: Article
Times cited : (63)

References (40)
  • 2
    • 84902140986 scopus 로고    scopus 로고
    • Ham-Wasserman Lecture
    • Burnett A: Ham-Wasserman Lecture. In; https://ash.confex. com/ash/2012/webprogram/Session3976.html. 2012.
    • (2012)
    • Burnett, A.1
  • 4
    • 84868622990 scopus 로고    scopus 로고
    • Bruton's tyrosine kinase: oncotarget in myeloma
    • Tai YT, Anderson KC. Bruton's tyrosine kinase: oncotarget in myeloma. Oncotarget. 2012, 3:913-914.
    • (2012) Oncotarget , vol.3 , pp. 913-914
    • Tai, Y.T.1    Anderson, K.C.2
  • 6
    • 84862829783 scopus 로고    scopus 로고
    • The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
    • Honda F, Kano H, Kanegane H, Nonoyama S, Kim E-S, Lee S-K, Takagi M, Mizutani S, Morio T. The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils. Nat Immunol. 2012, 13:369-378.
    • (2012) Nat Immunol , vol.13 , pp. 369-378
    • Honda, F.1    Kano, H.2    Kanegane, H.3    Nonoyama, S.4    Kim, E.-S.5    Lee, S.-K.6    Takagi, M.7    Mizutani, S.8    Morio, T.9
  • 9
    • 84880654363 scopus 로고    scopus 로고
    • Emerging drug profiles: Bruton tyrosine kinase (BTK) inhibitor ibrutinib (PCI-32765)
    • Burger JA, Buggy JJ. Emerging drug profiles: Bruton tyrosine kinase (BTK) inhibitor ibrutinib (PCI-32765). Leuk Lymphoma. 2013.
    • (2013) Leuk Lymphoma
    • Burger, J.A.1    Buggy, J.J.2
  • 13
    • 84886852386 scopus 로고    scopus 로고
    • Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Blocks Hairy Cell Leukemia (HCL) Survival, Proliferation, and BCR Signaling: A New Therapeutic Approach for HCL
    • Sivina M, Kreitman RJ, Arons E, Buggy JJ, Ravandi F, Burger JA. Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Blocks Hairy Cell Leukemia (HCL) Survival, Proliferation, and BCR Signaling: A New Therapeutic Approach for HCL. ASH Annual Meeting Abstracts. 2012, 120:1802.
    • (2012) ASH Annual Meeting Abstracts , vol.120 , pp. 1802
    • Sivina, M.1    Kreitman, R.J.2    Arons, E.3    Buggy, J.J.4    Ravandi, F.5    Burger, J.A.6
  • 14
    • 84875055944 scopus 로고    scopus 로고
    • The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
    • Dasmahapatra G, Patel H, Dent P, Fisher RI, Friedberg J, Grant S. The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib. British Journal of Haematology. 2013, 161:43-56.
    • (2013) British Journal of Haematology , vol.161 , pp. 43-56
    • Dasmahapatra, G.1    Patel, H.2    Dent, P.3    Fisher, R.I.4    Friedberg, J.5    Grant, S.6
  • 19
    • 84897853580 scopus 로고    scopus 로고
    • Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
    • Rushworth SA, Murray MY, Zaitseva L, Bowles KM, MacEwan DJ. Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood. 2014, 123:1229-1238.
    • (2014) Blood , vol.123 , pp. 1229-1238
    • Rushworth, S.A.1    Murray, M.Y.2    Zaitseva, L.3    Bowles, K.M.4    MacEwan, D.J.5
  • 22
    • 84859398461 scopus 로고    scopus 로고
    • Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
    • Burger JA. Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia. ASH Education Program Book. 2011, 2011:96-103.
    • (2011) ASH Education Program Book , vol.2011 , pp. 96-103
    • Burger, J.A.1
  • 23
    • 84896843067 scopus 로고    scopus 로고
    • A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity
    • Ablett MP, O'Brien CS, Sims AH, Farnie G, Clarke RB. A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity. Oncotarget. 2014, 5:599-612.
    • (2014) Oncotarget , vol.5 , pp. 599-612
    • Ablett, M.P.1    O'Brien, C.S.2    Sims, A.H.3    Farnie, G.4    Clarke, R.B.5
  • 24
    • 2642710893 scopus 로고    scopus 로고
    • The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
    • Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998, 91:4523-4530.
    • (1998) Blood , vol.91 , pp. 4523-4530
    • Mohle, R.1    Bautz, F.2    Rafii, S.3    Moore, M.A.4    Brugger, W.5    Kanz, L.6
  • 25
    • 84858636448 scopus 로고    scopus 로고
    • The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
    • de Rooij MFM, Kuil A, Geest CR, Eldering E, Chang BY, Buggy JJ, Pals ST, Spaargaren M. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. Blood. 2012, 119:2590-2594.
    • (2012) Blood , vol.119 , pp. 2590-2594
    • de Rooij, M.F.M.1    Kuil, A.2    Geest, C.R.3    Eldering, E.4    Chang, B.Y.5    Buggy, J.J.6    Pals, S.T.7    Spaargaren, M.8
  • 30
    • 0026634286 scopus 로고
    • Pertussis toxin and target eukaryotic cells: binding, entry, and activation
    • Kaslow HR, Burns DL. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. Faseb j. 1992, 6:2684-2690.
    • (1992) Faseb j , vol.6 , pp. 2684-2690
    • Kaslow, H.R.1    Burns, D.L.2
  • 32
    • 0027358430 scopus 로고
    • The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
    • de Weers M, Verschuren MCM, Kraakman MEM, Mensink RGJ, Schuurman RKB, van Dongen JJM, Hendriks RW. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. European Journal of Immunology. 1993, 23:3109-3114.
    • (1993) European Journal of Immunology , vol.23 , pp. 3109-3114
    • de Weers, M.1    Verschuren, M.C.M.2    Kraakman, M.E.M.3    Mensink, R.G.J.4    Schuurman, R.K.B.5    van Dongen, J.J.M.6    Hendriks, R.W.7
  • 34
    • 79251565218 scopus 로고    scopus 로고
    • Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
    • Fiedler K, Sindrilaru A, Terszowski G, Kokai E, Feyerabend TB, Bullinger L, Rodewald H-R, Brunner C. Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia. Blood. 2011, 117:1329-1339.
    • (2011) Blood , vol.117 , pp. 1329-1339
    • Fiedler, K.1    Sindrilaru, A.2    Terszowski, G.3    Kokai, E.4    Feyerabend, T.B.5    Bullinger, L.6    Rodewald, H.-R.7    Brunner, C.8
  • 35
    • 84892163011 scopus 로고    scopus 로고
    • MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen
    • Fiedler K, Kokai E, Bresch S, Brunner C. MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen. Am J Blood Res. 2013, 3:124-140.
    • (2013) Am J Blood Res , vol.3 , pp. 124-140
    • Fiedler, K.1    Kokai, E.2    Bresch, S.3    Brunner, C.4
  • 38
    • 79953665817 scopus 로고    scopus 로고
    • FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
    • Rushworth SA, Zaitseva L, Langa S, Bowles KM, MacEwan DJ. FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism. Oncotarget. 2011, 1:359-366.
    • (2011) Oncotarget , vol.1 , pp. 359-366
    • Rushworth, S.A.1    Zaitseva, L.2    Langa, S.3    Bowles, K.M.4    MacEwan, D.J.5
  • 39
    • 84859725212 scopus 로고    scopus 로고
    • Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1
    • Heasman SA, Zaitseva L, Bowles KM, Rushworth SA, MacEwan DJ. Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1. Oncotarget. 2011, 2:658-668.
    • (2011) Oncotarget , vol.2 , pp. 658-668
    • Heasman, S.A.1    Zaitseva, L.2    Bowles, K.M.3    Rushworth, S.A.4    MacEwan, D.J.5
  • 40
    • 43549095276 scopus 로고    scopus 로고
    • HO-1 underlies resistance of AML cells to TNF-induced apoptosis
    • Rushworth SA, MacEwan DJ. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood. 2008, 111:3793-3801.
    • (2008) Blood , vol.111 , pp. 3793-3801
    • Rushworth, S.A.1    MacEwan, D.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.